쎌바이오텍 사업보고서 (2016.12)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 22기	제 21기	제 20기

(2016년12월말)	(2015년12월말)	(2014년12월말)

[유동자산]	69,267,535,256	54,150,513,012	38,800,498,113

·현금및현금성자산	10,594,468,521	7,272,875,829	5,385,808,119

·매출채권및기타유동채권	10,792,304,471	9,311,574,554	8,354,572,007

·금융상품자산	45,198,950,000	34,606,184,587	22,138,811,666

·단기투자자산	-	-	308,852,595

·재고자산	2,052,900,092	2,521,478,081	1,985,857,841

·기타유동자산	628,912,172	438,399,961	626,595,885

[비유동자산]	21,261,696,865	20,817,336,026	18,803,634,418

·장기매출채권및기타비유동채권	342,479,173	264,874,621	226,520,721

·금융상품자산	5,000,000	505,000,000	506,000,000

·장기투자증권	266,592,405	287,043,173	488,062,169

·유형자산	19,524,253,609	18,780,486,861	16,769,895,823

·무형자산	939,269,664	843,148,796	679,982,615

·이연법인세자산	184,102,014	136,782,575	133,173,090

자 산 총 계	90,529,232,121	74,967,849,038	57,604,132,531

[유동부채]	6,360,902,280	6,163,135,072	5,206,116,240

[비유동부채]	15,476,000	47,462,020	37,462,020

부 채 총 계	6,376,378,280	6,210,597,092	5,243,578,260

[지배기업 소유주지분]	84,152,853,841	68,757,251,946	52,360,554,271

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	33,453,542	48,368,033	(1,189,378)

[이익잉여금]	71,920,072,650	56,509,556,264	40,162,416,000

[비지배지분]	-	-	-

자 본 총 계	84,152,853,841	68,757,251,946	52,360,554,271

기 간	(2016.01.01~	(2015.01.01~	(2014.01.01~

2016.12.31)	2015.12.31)	2014.12.31)

매출액	58,275,830,849	49,504,515,603	40,767,743,986

영업이익	21,561,007,533	18,758,807,947	12,905,528,179

당기순이익	18,498,516,386	17,505,140,264	10,402,695,484

지배기업 소유주지분	18,483,601,895	17,505,140,264	10,402,695,484

비지배지분	-	-	-

주당순이익	2,396	2,268	1,347

연결에포함된회사수	3	3	3

나.요약별도재무정보

구 분	제 22기	제 21기	제 20기

(2016년12월말)	(2015년12월말)	(2014년12월말)

[유동자산]	68,130,327,104	53,860,925,500	38,348,055,313

·현금및현금성자산	10,048,170,009	6,822,021,385	4,924,776,918

·매출채권및기타유동채권	11,300,441,465	10,418,352,866	9,337,826,816

·금융상품자산	44,298,950,000	33,706,184,587	21,238,811,666

·단기투자자산	-	-	308,852,595

·재고자산	1,995,382,673	2,488,101,480	1,936,220,896

·기타유동자산	487,382,957	426,265,182	601,566,422

[비유동자산]	23,717,557,562	22,233,829,427	20,442,417,308

·장기매출채권및기타비유동채권	37,850,411	8,850,411	8,850,411

·금융상품자산	5,000,000	505,000,000	506,000,000

·투자자산	166,528,857	224,009,929	461,164,833

·종속기업투자주식	3,218,445,020	2,118,819,740	2,065,845,531

·유형자산	19,386,662,974	18,616,137,994	16,701,018,122

·무형자산	775,249,663	689,416,428	644,222,381

·이연법인세자산	127,820,637	71,594,925	55,316,030

자 산 총 계	91,847,884,666	76,094,754,927	58,790,472,621

[유동부채]	6,216,204,771	5,415,695,302	4,263,932,125

[비유동부채]	20,476,000	47,677,600	37,677,600

부 채 총 계	6,236,680,771	5,463,372,902	4,301,609,725

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	(592,760)	(3,298,882)	26,926,508

[이익잉여금]	73,412,469,006	58,435,353,258	42,262,608,739

자 본 총 계	85,611,203,895	70,631,382,025	54,488,862,896

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2016.01.01~	(2015.01.01~	(2014.01.01~

2016.12.31)	2015.12.31)	2014.12.31)

매출액	56,495,596,508	49,024,773,708	40,461,684,447

영업이익	21,126,350,787	19,214,527,103	14,616,719,951

당기순이익	18,065,115,748	17,330,744,519	12,034,346,815

주당순이익	2,340	2,245	1,559